These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17218006)

  • 1. Reducible poly(amido ethylenimine) directed to enhance RNA interference.
    Hoon Jeong J; Christensen LV; Yockman JW; Zhong Z; Engbersen JF; Jong Kim W; Feijen J; Wan Kim S
    Biomaterials; 2007 Apr; 28(10):1912-7. PubMed ID: 17218006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery.
    Christensen LV; Chang CW; Kim WJ; Kim SW; Zhong Z; Lin C; Engbersen JF; Feijen J
    Bioconjug Chem; 2006; 17(5):1233-40. PubMed ID: 16984133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
    Kim SH; Lee SH; Tian H; Chen X; Park TG
    J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
    Kim SH; Mok H; Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of poly(amido amine)s as vectors for siRNA delivery.
    van der Aa LJ; Vader P; Storm G; Schiffelers RM; Engbersen JF
    J Control Release; 2011 Mar; 150(2):177-86. PubMed ID: 21130817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductive degradation behavior of bioreducible poly(disulfide amine) for enhancing SiRNA efficiency.
    Kim SH; Ou M; Bull DA; Kim SW
    Macromol Biosci; 2010 Aug; 10(8):898-905. PubMed ID: 20437407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
    Shim MS; Kwon YJ
    J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
    Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
    Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.
    Chen J; Tian H; Guo Z; Xia J; Kano A; Maruyama A; Jing X; Chen X
    Macromol Biosci; 2009 Dec; 9(12):1247-53. PubMed ID: 19890950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.
    Mok H; Park TG
    Biopolymers; 2008 Oct; 89(10):881-8. PubMed ID: 18521895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide.
    Lee SH; Kim SH; Park TG
    Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.